Wegovy vs. Foundayo for Weight Loss

Secondary Benefits

These medications offer potential benefits beyond weight loss as well.

“Due to these findings, oral Wegovy would currently be my preferred choice when cardiovascular risk reduction is top priority,” says Anton, noting that both medications seem promising for people focused primarily on blood glucose control or creating modest improvements in blood pressure and cholesterol.

There’s early evidence to suggest that GLP-1 medications may help curb addictive behaviors as well, says Richard Frank, MD, the West Palm Beach, Florida–based chief medical officer for Vida Health, a medical weight loss program.

“There is also growing interest in whether GLP-1 medications may help with nicotine dependence, binge eating disorder, and other compulsive reward-driven behaviors,” says Anton. “Larger randomized controlled trials are still needed before these medications become [part of] evidence-based standards of care [for these uses].”